4th Quarter - Report

INDEPENDENT PHARMACY COOPERATIVE for INDEPENDENT PHARMACY COOPERATIVE

Firm
Client
Income
—
Expenses
$10,000
Expense method
A: Lobbying Disclosure Act definitions

What was lobbied

One issue area, each in the filer's own words, with who lobbied on it and where.

Pharmacy PHA

CMS Average Manufacturer Price (AMP) Final Rule. Reporting by manufacturers and calculation. S. 274 The Medication Management Empowerment Act of 2011. All provisions S. 1002 Prohibit Theft of Medical Products 2011. All provisions. Potential prescription drug track-and-trace legislation. CMS Medicare Part B diabetic supply audits Region D. Concerns with scope and requirements of audit.

LobbyistCovered position, as disclosed
JIM DRISCOLL —
MARK EUGENE KINNEY —

Contacted: HOUSE OF REPRESENTATIVES; SENATE; Centers For Medicare and Medicaid Services (CMS)

Bills named: S. 1002 (112th), S. 274 (112th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.